Compound Global Advisors’s Eli Lilly LLY Stock Holding History

Compound Global Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$108K	Buy	90 +30	+50%	+$30.7K	2.67%	13
2026 Q1	$55.2K	Sell	60 -11	-15%	-$11.2K	1.71%	21
2025 Q4	$76.3K	Hold	71	–	–	4.23%	8
2025 Q3	$54.2K	Hold	71	–	–	2.94%	13
2025 Q2	$55.3K	Sell	71 -279	-80%	-$217K	5.05%	11
2025 Q1	$289K	Sell	350 -250	-42%	-$208K	1.71%	23
2024 Q4	$463K	Buy	+600	New	+$497K	1.88%	21
2024 Q1	$7.84M	Hold	10,079	–	–	1.17%	27
2023 Q4	$5.88M	Buy	10,079 +1,841	+22%	+$1.07M	1.09%	33
2023 Q3	$1.41M	Buy	+8,238	New	+$4.24M	0.31%	35

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Compound Global Advisors's LLY Position: Q2 2026 in Review

Compound Global Advisors increased its Eli Lilly (LLY) stake by 50% in Q2 2026, buying an estimated $30.7K and bringing the position to 90 shares worth $108K. The position accounts for 2.67% of the portfolio, ranked #13.

Compound Global Advisors first reported a position in LLY in Q3 2023 and has held it in 10 quarters since. The position peaked at $7.84M in Q1 2024. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Compound Global Advisors held 90 shares of Eli Lilly worth $108K as of Q2 2026.
Compound Global Advisors bought 30 Eli Lilly shares in Q2 2026, an estimated $30.7K.
Eli Lilly made up 2.67% of Compound Global Advisors's portfolio in Q2 2026, its #13 holding.
Compound Global Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 10 quarters since.
Compound Global Advisors's Eli Lilly position peaked at $7.84M in Q1 2024.
4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Compound Global Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.